Jane Street Group, LLC Vir Biotechnology, Inc. Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$21.19 - $40.01 $2.17 Million - $4.11 Million	-102,600 Reduced 47.35%	114,100 $2.94 Million
Q4 2021 Feb 15, 2022	BUY	$30.97 - $54.03 $4.43 Million - $7.74 Million	143,200 Added 194.83%	216,700 $9.07 Million
Q3 2021 Nov 16, 2021	BUY	$34.9 - $54.54 $554,910 - $867,186	15,900 Added 27.6%	73,500 $3.2 Million
Q2 2021 Aug 16, 2021	SELL	$38.75 - $51.0 $2.03 Million - $2.67 Million	-52,400 Reduced 47.64%	57,600 $2.72 Million
Q1 2021 May 18, 2021	BUY	$26.34 - $83.07 $1.54 Million - $4.87 Million	58,600 Added 114.01%	110,000 $5.64 Million
Q4 2020 Feb 17, 2021	SELL	$25.51 - $43.38 $216,835 - $368,730	-8,500 Reduced 14.19%	51,400 $1.38 Million
Q3 2020 Nov 17, 2020	BUY	$28.28 - $53.6 $1.18 Million - $2.24 Million	41,800 Added 230.94%	59,900 $2.06 Million
Q2 2020 Aug 17, 2020	BUY	$27.89 - $47.86 $504,809 - $866,266	18,100 New	18,100 $742,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.